Literature DB >> 23123519

Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial.

Anneke Grobler, Salim Abdool Karim.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23123519     DOI： 10.1097/QAD.0b013e328355ce08

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

1.  Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures.

Authors:  Isabella Bon; David Lembo; Marco Rusnati; Alberto Clò; Silvia Morini; Anna Miserocchi; Antonella Bugatti; Sonia Grigolon; Giuseppina Musumeci; Santo Landolfo; Maria Carla Re; Davide Gibellini
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

2.  Measuring the potential role of frailty in apparent declining efficacy of HIV interventions.

Authors:  Felicia P Hardnett; Charles E Rose
Journal:  HIV Clin Trials       Date:  2015-12-12

3.  Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides.

Authors:  Cristina Tintori; Giulia Iovenitti; Elisa Rita Ceresola; Roberto Ferrarese; Claudio Zamperini; Annalaura Brai; Giulio Poli; Elena Dreassi; Valeria Cagno; David Lembo; Filippo Canducci; Maurizio Botta
Journal:  PLoS One       Date:  2018-06-05       Impact factor: 3.240

4.  Herpes simplex virus type-2 stimulates HIV-1 replication in cervical tissues: implications for HIV-1 transmission and efficacy of anti-HIV-1 microbicides.

Authors:  C Rollenhagen; M J Lathrop; S L Macura; G F Doncel; S N Asin
Journal:  Mucosal Immunol       Date:  2014-02-05       Impact factor: 7.313
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.